Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REQUIP vs RESMETIROM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REQUIP vs RESMETIROM: Safety Overview

Metric REQUIP RESMETIROM
Total FAERS Reports 157 881
Deaths Reported 6 26
Death Rate 3.8% 3.0%
Hospitalizations 37 50
Average Patient Age 64.8 yrs 58.1 yrs
% Female Patients N/A 65.3%
FDA Approval Date N/A Mar 14, 2024
Manufacturer N/A Madrigal Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription